1. Home
  2. FBLA vs FDMT Comparison

FBLA vs FDMT Comparison

Compare FBLA & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBLA
  • FDMT
  • Stock Information
  • Founded
  • FBLA 1908
  • FDMT 2013
  • Country
  • FBLA United States
  • FDMT United States
  • Employees
  • FBLA N/A
  • FDMT N/A
  • Industry
  • FBLA
  • FDMT Biotechnology: Pharmaceutical Preparations
  • Sector
  • FBLA
  • FDMT Health Care
  • Exchange
  • FBLA NYSE
  • FDMT Nasdaq
  • Market Cap
  • FBLA 226.5M
  • FDMT 192.2M
  • IPO Year
  • FBLA N/A
  • FDMT 2020
  • Fundamental
  • Price
  • FBLA $11.24
  • FDMT $3.89
  • Analyst Decision
  • FBLA
  • FDMT Buy
  • Analyst Count
  • FBLA 0
  • FDMT 10
  • Target Price
  • FBLA N/A
  • FDMT $32.33
  • AVG Volume (30 Days)
  • FBLA 215.7K
  • FDMT 493.1K
  • Earning Date
  • FBLA 08-22-2025
  • FDMT 08-07-2025
  • Dividend Yield
  • FBLA N/A
  • FDMT N/A
  • EPS Growth
  • FBLA N/A
  • FDMT N/A
  • EPS
  • FBLA N/A
  • FDMT N/A
  • Revenue
  • FBLA $66,405,000.00
  • FDMT $23,000.00
  • Revenue This Year
  • FBLA N/A
  • FDMT $13,048.65
  • Revenue Next Year
  • FBLA N/A
  • FDMT N/A
  • P/E Ratio
  • FBLA N/A
  • FDMT N/A
  • Revenue Growth
  • FBLA N/A
  • FDMT N/A
  • 52 Week Low
  • FBLA $9.81
  • FDMT $2.24
  • 52 Week High
  • FBLA $12.74
  • FDMT $28.93
  • Technical
  • Relative Strength Index (RSI)
  • FBLA N/A
  • FDMT 52.66
  • Support Level
  • FBLA N/A
  • FDMT $3.73
  • Resistance Level
  • FBLA N/A
  • FDMT $4.13
  • Average True Range (ATR)
  • FBLA 0.00
  • FDMT 0.33
  • MACD
  • FBLA 0.00
  • FDMT -0.06
  • Stochastic Oscillator
  • FBLA 0.00
  • FDMT 24.82

About FBLA FB BANCORP INC

FB Bancorp Inc is a holding company. The company operates through its subsidiary Fidelity Bank. Fidelity business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market areas. The services of the company also include residential construction loans, commercial real estate loans (which includes commercial mortgage, commercial construction and land development loans), commercial loans (which includes commercial and industrial, small business and other commercial loans not secured by real estate), home equity loans and lines of credit, and consumer loans.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Share on Social Networks: